key: cord-0065984-4invoy5u
authors: Wu, Xu; Bao, Linlin; Hu, Ziqi; Yao, Duoduo; Li, Fengdi; Li, Hui; Xu, Xiaoxue; An, Yunqing; Wang, Xi; Cao, Bin; Zhang, Xulong
title: Ficolin A exacerbates severe H1N1 influenza virus infection-induced acute lung immunopathological injury via excessive complement activation
date: 2021-07-23
journal: Cell Mol Immunol
DOI: 10.1038/s41423-021-00737-1
sha: 82148add8e8633e89023df65cd64dd6df272bd54
doc_id: 65984
cord_uid: 4invoy5u

nan

Severe pandemic influenza A (H1N1) 2009 virus (pH1N1) infection causes significant morbidity and mortality. We and other groups have reported that immunopathological damage induced by excessive pulmonary inflammation plays a critical role in the pathogenesis of severe pneumonia and provides novel strategies for the treatment of severe influenza infection [1] [2] [3] . The complement system plays critical roles in both innate and adaptive immunity by activating the classical, alternative and lectin pathways [4] . As soluble pattern recognition lectin molecules, ficolins are enriched in the lungs and are essential for protecting the host from invading pathogens [5] . In our previous report, low-dose lipopolysaccharide (LPS) inoculation simulated bacterial infection-induced mild pneumonia without death in mice. We found that intranasal LPS administration induced local pulmonary inflammation and increased the recruitment of macrophages and neutrophils and the expression of ficolin A and ficolin B. LPS-challenged ficolin A-knockout (Fcna −/− ) mice showed more severe lung injury than LPS-challenged wildtype (WT) mice. These results suggest that the protective effect of ficolin A may be associated with complement activation, as well as the neutralization of LPS [6] . However, complement is a doubleedged sword. Complement activation also triggers potent detrimental hyperinflammatory responses that cause tissue damage and organ failure when these responses are dysregulated or overactivated [7] . Therefore, whether ficolins play protective or detrimental roles in severe pH1N1 infection and their mechanisms need to be investigated. Our results demonstrated that ficolin Amediated excessive complement activation exacerbates pulmonary proinflammatory responses and contributes to lung immunopathological injury. Targeting ficolin A may be a potential adjunctive therapeutic strategy for alleviating severe influenzainduced viral pneumonia.

To explore the dynamic changes of ficolins during pH1N1 infection-induced severe pneumonia, we initially measured the mRNA and protein levels of ficolins in the lung. Severe infection significantly increased the transcription of ficolin A at 3, 5 and 7 dpi and ficolin B at 1 dpi (Fig. S1a) . Moreover, severe infection also gradually increased the expression of ficolin A and significantly increased ficolin B at 3 dpi (Fig. 1a) . Furthermore, ficolin A was mainly expressed in neutrophils (Fig. S1b ), while ficolin B was expressed in neutrophils, alveolar macrophages, interstitial macrophages and inflammatory monocytes (Fig. S1c) . Similar results were also confirmed by immunofluorescence analysis (Fig.  S1d) .

Fcna −/− and Ficolin B-knockout (Fcnb −/− ) mice were further used to assess the roles of these genes in pH1N1-induced severe pneumonia. Notably, compared with WT and Fcnb −/− mice, Fcna −/− mice showed significant improvements in survival rates (62.5% in Fcna −/− mice vs 25% in WT and Fcnb −/− mice), less weight loss and faster weight recovery (Fig. 1b) . Moreover, lung histopathological injury [the total protein concentration in bronchoalveolar lavage fluid (BALF) and lung bronchial and parenchymal destruction, including hemorrhage, alveolar edema, alveolar fusion, and bronchiolar epithelial sloughing] was significantly ameliorated, and inflammatory cell infiltration was attenuated in Fcna −/− mice compared with WT mice (Fig. 1c,d and S2a ). These results suggested that ficolin A but not ficolin B could exacerbate pH1N1-induced lung injury and decrease the survival rate.

Direct destruction of infected cells by viruses or overactivated immune systems are related to lung histopathological injury. We found that Fcna −/− and Fcnb −/− mice showed similar levels of viral replication by immunohistochemical or Western blot analysis of hemagglutinin protein in the lung (Fig. S2b-d) . These results suggested that the detrimental effects of ficolin A were independent of viral replication.

The stimulation of excessive inflammatory cell infiltration and cytokine storms are also critical pathogeneses [8, 9] . After severe pH1N1 infection in WT mice, alveolar macrophages were progressively decreased, and a large number of neutrophils, inflammatory monocytes and pulmonary interstitial macrophages i Graphic summary of the mechanisms underlying ficolin-mediated lung immunopathological damage during pH1N1 infection. The data are representative of two independent experiments and are presented as the mean ± SD (n = 5 mice/group in each experiment). *, ** and *** represent p < 0.05, 0.01 and 0.001, respectively, compared with the 0 dpi (uninfected) group. #, ## and ### represent p < 0.05, 0.01 and 0.001, respectively. ns = not significant were rapidly recruited to the lung, peaking at 3 dpi (Fig. S3a) . However, severe pH1N1-infected Fcna −/− mice but not Fcnb −/− mice showed significantly decreased percentages and numbers of neutrophils, inflammatory monocytes and interstitial macrophages compared with those of WT mice (Fig. 1e,f) . Moreover, the proportions and numbers of alveolar macrophages in Fcna −/− mice were similar to those in WT and Fcnb −/− mice (Fig. S3b) . We also examined whether the amelioration of lung injury in Fcna −/− mice was associated with the alleviation of cytokine storms. Severe pH1N1 infection in WT mice induced the release of large amounts of cytokines and chemokines, including TNFα, IL-6, IFNα, IFNβ, IFNγ, G-CSF, CCL2, CCL5, and CXCL1 (Fig. S3c) . Compared with those of WT and Fcnb −/− mice, the concentrations of TNFα, IL-6, CCL2, CXCL1, and G-CSF in the BALF of Fcna −/− mice were markedly suppressed at 3, 5, and 7 dpi (Fig. 1g) . These results suggested that ficolin A but not ficolin B exacerbated lung injury and mortality by enhancing inflammatory cell recruitment and proinflammatory cytokine/chemokine release during severe pH1N1 infection.

Ficolins can activate the complement lectin pathway to produce the anaphylatoxins C3a and C5a [5] . We observed increased levels of C3a and C5a in BALF. However, compared with those of WT mice, the concentrations of C3a and C5a were significantly decreased in Fcna −/− but not Fcnb −/− mice (Fig. 1h) . These results demonstrated that ficolin A-mediated complement activation was involved in severe infection-induced lung immunopathological damage.

In conclusion, our results demonstrated that pulmonary myeloidderived ficolin A may be linked to proinflammatory mediators, which contribute to complement activation and boost the inflammatory response in severe pH1N1 infection-induced acute lung immunopathological injury (Fig. 1i) . Preventing the stimulation of dysregulated host innate immune response may abrogate the immunopathological damage caused by severe influenza infection.

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China

Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration

The cytokine storm of severe influenza and development of immunomodulatory therapy

New insights into the immune functions of complement

The influence of the lectin pathway of complement activation on infections of the respiratory system

Ficolin A derived from local macrophages and neutrophils protects against lipopolysaccharide-induced acute lung injury by activating complement

Therapeutic targeting of the complement system: From rare diseases to pandemics

Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract

New fronts emerge in the influenza cytokine storm

XW, LB, ZH, DY, FL, HL and XX performed the experiments; YA and XW verified the experimental procedure and data; XW, BC, and XZ analyzed the data and wrote the paper; BC and XZ designed and supervised the study.

The authors declare no competing interests.

Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41423-021-00737-1.Correspondence and requests for materials should be addressed to B.C. or X.Z.Reprints and permission information is available at http://www.nature.com/ reprints